Publications by authors named "Monica Fornier"

63Publications

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.

NPJ Breast Cancer 2019 29;5:26. Epub 2019 Aug 29.

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0123-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715716PMC
August 2019

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Clin Breast Cancer 2018 10 15;18(5):387-394. Epub 2018 Mar 15.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682312PMC
October 2018

Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

JAMA Dermatol 2018 06;154(6):670-675

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.0454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145643PMC
June 2018

Less Intense Dosing Schedule for a Bone-Modifying Agent.

Authors:
Monica N Fornier

JAMA Oncol 2017 07;3(7):893-894

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6240DOI Listing
July 2017

Denosumab and fracture risk in women with breast cancer.

Lancet 2015 Nov 20;386(10008):2056-2057. Epub 2015 Nov 20.

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00973-3DOI Listing
November 2015

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Breast J 2012 Jul-Aug;18(4):345-50. Epub 2012 May 21.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2012.01246.xDOI Listing
April 2013

The paradox of triple negative breast cancer: novel approaches to treatment.

Breast J 2012 Jan-Feb;18(1):41-51. Epub 2011 Nov 20.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1524-4741.2011.01175.x
Publisher Site
http://dx.doi.org/10.1111/j.1524-4741.2011.01175.xDOI Listing
September 2012

Approved agents for metastatic breast cancer.

Authors:
Monica N Fornier

Semin Oncol 2011 Jun;38 Suppl 2:S3-10

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.04.003DOI Listing
June 2011

Denosumab: second chapter in controlling bone metastases or a new book?

Authors:
Monica N Fornier

J Clin Oncol 2010 Dec 8;28(35):5127-31. Epub 2010 Nov 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.0128DOI Listing
December 2010

Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials.

Authors:
Monica Fornier

Clin Breast Cancer 2010 Oct;10(5):352-8

Division of Solid Tumor Oncology, Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.046DOI Listing
October 2010

Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines.

Clin Breast Cancer 2010 Sep;10 Suppl 2:S7-19

Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152682091170218
Publisher Site
http://dx.doi.org/10.3816/CBC.2010.s.008DOI Listing
September 2010

HER2-positive breast cancer: beyond trastuzumab.

Oncology (Williston Park) 2010 Apr;24(5):410-5

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
April 2010

Optimizing the use of anthracyclines in older patients with breast cancer.

Crit Rev Oncol Hematol 2011 Feb 12;77(2):131-41. Epub 2010 Mar 12.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 475 New York NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2010.02.001DOI Listing
February 2011

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Cancer Immunol Immunother 2010 Jun 6;59(6):885-97. Epub 2010 Feb 6.

Cellular Immunology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0815-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268513PMC
June 2010

Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.

Int J Radiat Oncol Biol Phys 2010 Jul 30;77(4):1105-12. Epub 2009 Oct 30.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160900955
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2009.06.042DOI Listing
July 2010

NCCN Task Force Report: Bone Health in Cancer Care.

J Natl Compr Canc Netw 2009 Jun;7 Suppl 3:S1-32; quiz S33-5

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047404PMC
http://dx.doi.org/10.6004/jnccn.2009.0076DOI Listing
June 2009

Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.

Clin Adv Hematol Oncol 2009 Feb;7(2):115-22

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
February 2009

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.

J Cancer Res Clin Oncol 2009 Sep 1;135(9):1215-21. Epub 2009 Mar 1.

Integrative Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0562-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751581PMC
September 2009

Novel anti-tubulin cytotoxic agents for breast cancer.

Expert Rev Anticancer Ther 2009 Feb;9(2):175-85

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.9.2.175DOI Listing
February 2009

Microtubule active agents: beyond the taxane frontier.

Clin Cancer Res 2008 Nov;14(22):7167-72

Memorial Sloan-Kettering Cancer Center, Breast Cancer Medicine Service, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0169DOI Listing
November 2008

Osteonecrosis of the jaw related to bevacizumab.

J Clin Oncol 2008 Aug;26(24):4037-8

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.5424DOI Listing
August 2008

Epothilones in breast cancer: current status and future directions.

Expert Rev Anticancer Ther 2008 Aug;8(8):1299-311

Department of Medical Oncology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 08001 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.8.8.129
Publisher Site
http://dx.doi.org/10.1586/14737140.8.8.1299DOI Listing
August 2008

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.

Cancer 2008 Sep;113(6):1294-301

Department of Hematology-Oncology, Penn State Hershey Cancer Center, Penn State University/Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23689DOI Listing
September 2008

Anabolic therapies for osteoporosis.

N Engl J Med 2007 Dec;357(23):2410-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc076405DOI Listing
December 2007

Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.

Authors:
Monica N Fornier

Clin Breast Cancer 2007 Oct;7(10):757-63

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
October 2007

Long-term clinical outcomes of whole-breast irradiation delivered in the prone position.

Int J Radiat Oncol Biol Phys 2007 May 6;68(1):73-81. Epub 2007 Mar 6.

Department of Radiation Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.11.054DOI Listing
May 2007

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.

Cancer 2005 Oct;104(8):1575-9

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21385DOI Listing
October 2005

Dose-dense adjuvant chemotherapy for primary breast cancer.

Breast Cancer Res 2005 10;7(2):64-9. Epub 2005 Feb 10.

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064124PMC
January 2006

Adjuvant chemotherapy for primary breast cancer.

Curr Oncol Rep 2005 Jan;7(1):18-22

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 457, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-005-0021-1DOI Listing
January 2005

Risk models for neutropenia in patients with breast cancer.

Oncology (Williston Park) 2003 Nov;17(11 Suppl 11):14-20

Breast Cancer Medical Service, Memorial Sloan-Kettering, Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
November 2003

HER2 testing and correlation with efficacy of trastuzumab therapy.

Oncology (Williston Park) 2002 Oct;16(10):1340-8, 1351-2; discussion 1352, 1355-8

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
October 2002

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review).

Int J Oncol 2002 Jun;20(6):1283-8

Operative Unit of Medical Oncology, Oncology Institute of Bari, Italy.

View Article

Download full-text PDF

Source
June 2002